Nanomedicine is the medical application of nanotechnology that ranges from the medical applications of nanomaterials and biological devices, to nanoelectronic biosensors, and even possible future applications of molecular nanotechnology such as biological machines. Nanomedicines are used globally to improve the treatments and lives of patients suffering from a range of disorders including ovarian and breast cancer, kidney disease, fungal infections, elevated cholesterol, menopausal symptoms, multiple sclerosis, chronic pain, asthma and emphysema.
The global nanomedicine market segmentation is based on applications (neurology, cardiology, oncology, anti-inflammatory, anti-infectives, etc.).
The global nanomedicine market report provides market size (Revenue USD Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021). The global nanomedicine market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
The oncology application segment dominated the market share of global nanomedicine market considering its advantages such as enabling drugs to cross blood brain barrier and targeting the tumors in brain and at other inner sites in the body. The cardiovascular application segment is the fastest growing segment of the market with higher growth rate and also during the forecast period. North America accounted for the largest share of the global nanomedicine market followed by Europe, while Asia Pacific region is likely to grow at a faster rate during the forecast period due to high unmet need and emerging economies.